Are you ready to make a difference and save lives? Join the St. Baldrick’s Foundation for the exciting 60-Mile Run Facebook Challenge to Conquer Kids’ Cancer. Throughout September, in honor of Childhood Cancer Awareness Month, take on the challenge of completing 60 miles in 30 days while raising funds for lifesaving research and bringing hope to children battling cancer.

A Challenge for Everyone:

Not interested in running? No problem! You can achieve the 60-mile goal by walking, cycling, hiking, or even dancing. The key is to complete the distance in a way that suits you, while contributing to the cause and enjoying your preferred activity.

Read more »

Ford is a commanding force, in all senses of the word. As a Leo born in August, he truly encompasses all traits of the fierce lion – courageous, fearless, and brave. Not only does he light up a room with his infectious smile, laughter and captivating voice, he draws everyone in like a magnet.

Ford smiling from ear to ear in his lion ears.

Read more »

Read more »

What are childhood sarcomas?

A sarcoma is a tumor that grows in the bone or soft tissue (muscles, nerves and fat) anywhere in the body. Sarcomas are rare, especially in young children, accounting for less than 15% of childhood cancers.

Pediatric sarcomas are classified into two major categories: bone sarcomas and soft tissue sarcomas.

Bone sarcomas can appear in any bone, but are most often seen in the leg, arm, pelvis or rib. The most common bone sarcomas are Ewing sarcoma and osteosarcoma.

Soft-tissue sarcomas can occur in any soft tissue, anywhere in the body. The most common soft-tissue sarcomas are embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma.

Within these two umbrella categories, there are many different types of sarcomas that can develop in children.

Sarcomas can start off being tiny lumps that you can’t feel. They can spread through the body, or metastasize, before they grow big enough to be seen.

Read more »

What is Ewing sarcoma?

Ewing sarcoma is a type of childhood cancer that is most frequently found in children and adolescents between the ages of 10 and 20 years old.

Ewing sarcoma — the second most common bone cancer after osteosarcoma — often originates in the long, large bones of the body, including the hip, thigh, shin, chest, and arm bones.

Read more »

What is alveolar rhabdomyosarcoma?

There are two main types of pediatric rhabdomyosarcoma: embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma.

• Embryonal rhabdomyosarcoma (ERMS) occurs most often in children under 10 years old and is found in the head, neck, urinary tract, or reproductive organs. It is the most common type.
• Alveolar rhabdomyosarcoma (ARMS) is more aggressive, occurs more commonly in teens or young adults, and usually starts in the torso, arms, or legs.

Rhabdomyosarcoma is the most common soft tissue cancer in children, with approximately 350 new cases each year in the United States.

Read more »

What is embryonal rhabdomyosarcoma?

Embryonal rhabdomyosarcoma is a malignant soft tissue tumor that is formed from embryonic skeletal muscle tissue, the type of tissue that grows into skeletal muscles.

When we think about skeletal muscles, we might first think of biceps or hamstrings, but embryonal rhabdomyosarcoma doesn’t usually start in the arms or legs. Most often, these tumors are seen in the head or neck, bladder, or reproductive organs.

Read more »

School is out, pools are open, and grills are fired up. Whether you want to make the most of the warm weather or you’re just looking for a way to get the kids involved, make this summer count by raising money to fund research that helps kids with cancer. Here are five ideas to get you started.

Read more »

Editor’s Note: As we commemorate National Cancer Survivor Month, we’d like to introduce you to Katrina Knott, whose daughter, Arianna, was one of the five St. Baldrick’s “Ambassadors” for 2019. As you’ll read in her story, survivorship issues in pediatric cancer need attention – and funding – for those like Arianna, whose challenges are many.

Arianna during treatment.

Read more »

For more than 40 years the main treatment for pediatric osteosarcoma has not changed. Patients with this type of aggressive bone cancer, most often diagnosed in teens, are in desperate need of new options. Fewer than 30% of patients survive when osteosarcoma has spread beyond the primary tumor at diagnosis.

To make a significant impact for kids fighting osteosarcoma, five funding partners have banded together with St. Baldrick’s to support a new grant – The Fight Osteosarcoma Together (FOT) Super Grant. Today we are excited to announce that the recipient of this three-year, $1.5 million grant is Dr. Patrick Grohar, at the Children’s Hospital of Philadelphia. The goal: a clinical trial to test a new treatment within three years.

Patrick J. Grohar, M.D., Ph.D.

Read more »